Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 231365, 12 pages
http://dx.doi.org/10.1155/2014/231365
Research Article

Discordant Correlation between Serological Assays Observed When Measuring Heterosubtypic Responses against Avian Influenza H5 and H7 Viruses in Unexposed Individuals

1Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Central Avenue, Chatham Maritime, Chatham ME4 4TB, UK
2Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 3, 53100 Siena, Italy

Received 28 February 2014; Revised 11 May 2014; Accepted 11 May 2014; Published 11 June 2014

Academic Editor: Yanjin Zhang

Copyright © 2014 Eleonora Molesti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. J. Cox, T. L. Brammer, and H. L. Regnery, “Influenza: global surveillance for epidemic and pandemic variants,” European Journal of Epidemiology, vol. 10, no. 4, pp. 467–470, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Veguilla, K. Hancock, J. Schiffer et al., “Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations,” Journal of Clinical Microbiology, vol. 49, no. 6, pp. 2210–2215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. A. Brokstad, R. J. Cox, D. Major, J. M. Wood, and L. R. Haaheim, “Cross-reaction but no avidity change of the serum antibody response after influenza vaccination,” Vaccine, vol. 13, no. 16, pp. 1522–1528, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. Powers and R. B. Belshe, “Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and ‘original antigenic sin’,” Journal of Infectious Diseases, vol. 169, no. 5, pp. 1125–1129, 1994. View at Google Scholar · View at Scopus
  5. J. L. Schulman and E. D. Kilbourne, “Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus,” Journal of bacteriology, vol. 89, pp. 170–174, 1965. View at Google Scholar · View at Scopus
  6. R. A. Yetter, W. H. Barber, and P. A. Small Jr., “Heterotypic immunity to influenza in ferrets,” Infection and Immunity, vol. 29, no. 2, pp. 650–653, 1980. View at Google Scholar · View at Scopus
  7. P. P. Heinen, E. A. de Boer-Luijtze, and A. T. Bianchi, “Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection,” Journal of General Virology, vol. 82, no. 11, pp. 2697–2707, 2001. View at Google Scholar · View at Scopus
  8. T. Han and W. A. Marasco, “Structural basis of influenza virus neutralization,” Annals of the New York Academy of Sciences, vol. 1217, no. 1, pp. 178–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. C. Ekiert, G. Bhabha, M.-A. Elsliger et al., “Antibody recognition of a highly conserved influenza virus epitope,” Science, vol. 324, no. 5924, pp. 246–251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Sui, W. C. Hwang, S. Perez et al., “Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses,” Nature Structural and Molecular Biology, vol. 16, no. 3, pp. 265–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Corti, J. Voss, S. J. Gamblin et al., “A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins,” Science, vol. 333, no. 6044, pp. 850–856, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. C. Ekiert, R. H. E. Friesen, G. Bhabha et al., “A highly conserved neutralizing epitope on group 2 influenza A viruses,” Science, vol. 333, no. 6044, pp. 843–850, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Tsuchiya, K. Sugawara, S. Hongo et al., “Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus,” Journal of General Virology, vol. 82, no. 10, pp. 2475–2484, 2001. View at Google Scholar · View at Scopus
  14. J.-M. Garcia, S. Pepin, N. Lagarde et al., “Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin,” PLoS ONE, vol. 4, no. 11, Article ID e7918, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Liu, Y. Liu, Y. Zhang et al., “Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population,” PLoS ONE, vol. 8, no. 3, Article ID e58810, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Plotkin, “Correlates of protection induced by vaccination,” Clinical and Vaccine Immunology, vol. 17, no. 7, pp. 1055–1065, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Kreijtz, R. A. Fouchier, and G. F. Rimmelzwaan, “Immune responses to influenza virus infection,” Virus Research, vol. 162, no. 1-2, pp. 19–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. A. Plotkin, “Vaccines: correlates of vaccine-induced immunity,” Clinical Infectious Diseases, vol. 47, no. 3, pp. 401–409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Al-Khayatt, R. Jennings, and C. W. Potter, “Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis,” Journal of Hygiene, vol. 93, no. 2, pp. 301–312, 1984. View at Google Scholar · View at Scopus
  20. J. M. Wood, E. Montomoli, R. W. Newman, A. Daas, K.-H. Buchheit, and E. Terao, “Collaborative study on influenza vaccine clinical trial serology—part 2: reproducibility study,” Pharmeuropa Bio & Scientific Notes, vol. 2011, no. 1, pp. 36–54, 2011. View at Google Scholar · View at Scopus
  21. W. A. Keitel and R. L. Atmar, “Vaccines for pandemic influenza: summary of recent clinical trials,” Current Topics in Microbiology and Immunology, vol. 333, no. 1, pp. 431–451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Ng, D. K. M. Ip, V. J. Fang et al., “The effect of age and recent influenza vaccination history on the immunogenicity and efficacy of 2009-10 seasonal trivalent inactivated influenza vaccination in children,” PLoS ONE, vol. 8, no. 3, Article ID e59077, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. W. E. P. Beyer, A. M. Palache, G. Lüchters, J. Nauta, and A. D. Osterhaus, “Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?” Virus Research, vol. 103, no. 1-2, pp. 125–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Wood, R. E. Gaines-Das, J. Taylor, and P. Chakraverty, “Comparison of influenza serological techniques by international collaborative study,” Vaccine, vol. 12, no. 2, pp. 167–174, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Eichelberger, H. Golding, M. Hess et al., “FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007,” Vaccine, vol. 26, no. 34, pp. 4299–4303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Krammer, N. Pica, R. Hai, I. Margine, and P. Palesea, “Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies,” Journal of Virology, vol. 87, no. 12, pp. 6542–6550, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. K. G. Nicholson, A. E. Colegate, A. Podda et al., “Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza,” The Lancet, vol. 357, no. 9272, pp. 1937–1943, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Rowe, R. A. Abernathy, J. Hu-Primmer et al., “Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays,” Journal of Clinical Microbiology, vol. 37, no. 4, pp. 937–943, 1999. View at Google Scholar · View at Scopus
  29. I. Stephenson, R. G. Das, J. M. Wood, and J. M. Katz, “Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study,” Vaccine, vol. 25, no. 20, pp. 4056–4063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Alberini, E. Del Tordello, A. Fasolo et al., “Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses,” Vaccine, vol. 27, no. 43, pp. 5998–6003, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J.-M. Garcia, N. Lagarde, E. S. Ma, M. D. de Jong, and J. S. Peiris, “Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay,” Journal of Clinical Virology, vol. 47, no. 1, pp. 29–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Molesti, A. Milani, C. Terregino, G. Cattoli, and N. J. Temperton, “Comparative serological assays for the study of h5 and h7 avian influenza viruses,” Influenza Research and Treatment, vol. 2013, Article ID 286158, 9 pages, 2013. View at Publisher · View at Google Scholar
  33. N. J. Temperton, K. Hoschler, D. Major et al., “A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies,” Influenza and Other Respiratory Viruses, vol. 1, no. 3, pp. 105–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Wang, E. N. Butler, V. Veguilla et al., “Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies,” Journal of Virological Methods, vol. 153, no. 2, pp. 111–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Hai, F. Krammer, G. S. Tan et al., “Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes,” Journal of Virology, vol. 86, no. 10, pp. 5774–5781, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Gentile, I. Manini, I. Alberini et al., “Seroepidemiology of influenza A/H5N1 virus in the Italian population from 1992 to 2007,” J. Katz, Ed., pp. 17–23, Toronto,Ontario, Canada, June 2007.
  37. WHO, WHO Global Influenza Surveillance Network: Manual for the Laboratory Diagnosis and Virological Survaillance of Influenza, WHO Press, Malta, 2011.
  38. N. Landry, B. J. Ward, S. Trépanier et al., “Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza,” PLoS ONE, vol. 5, no. 12, Article ID e15559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. W. A. Keitel, J. D. Campbell, J. J. Treanor et al., “Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial,” Journal of Infectious Diseases, vol. 198, no. 9, pp. 1309–1316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. European Committee for Medicinal Products for Human Use, Note for Guidance on Harmonisation of Requirements for influenza Vaccines, Industry ECoEa, Brussels, Belgium, 1997.
  41. E. Molesti, G. Cattoli, F. Ferrara, E. Böttcher-Friebertshäuser, C. Terregino, and N. Temperton, “The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses,” Journal of Molecular and Genetic Medicine, vol. 7, pp. 315–320, 2012. View at Google Scholar
  42. J. Sui, J. Sheehan, W. C. Hwang et al., “Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies,” Clinical Infectious Diseases, vol. 52, no. 8, pp. 1003–1009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. D. A. Kaminski and F. E. Lee, “Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design,” Frontiers in Immunology, vol. 2, article 76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J. S. Oxford, G. C. Schild, C. W. Potter, and R. Jennings, “The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection,” Journal of Hygiene, vol. 82, no. 1, pp. 51–61, 1979. View at Google Scholar · View at Scopus
  45. K. Farrohi, F. K. Farrohi, G. R. Noble, H. S. Kaye, and A. P. Kendal, “Evaluation of the single radial hemolysis test for measuring hemagglutinin- and neuraminidase-specific antibodies to H3N2 influenza strains and antibodies to influenza B,” Journal of Clinical Microbiology, vol. 5, no. 3, pp. 353–360, 1977. View at Google Scholar · View at Scopus
  46. M. L. Profeta and G. Palladino, “Serological evidence of human infections with avian influenza viruses. Brief report,” Archives of Virology, vol. 90, no. 3-4, pp. 355–360, 1986. View at Google Scholar · View at Scopus
  47. B. L. Lu, R. G. Webster, and V. S. Hinshaw, “Failure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions,” Infection and Immunity, vol. 38, no. 2, pp. 530–535, 1982. View at Google Scholar · View at Scopus
  48. D. Corti, A. L. Suguitan Jr., D. Pinna et al., “Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine,” Journal of Clinical Investigation, vol. 120, no. 5, pp. 1663–1673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. D. B. Burlington, P. F. Wright, K. L. van Wyke, M. A. Phelan, R. E. Mayner, and B. R. Murphy, “Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children,” Journal of Clinical Microbiology, vol. 21, no. 5, pp. 847–849, 1985. View at Google Scholar · View at Scopus
  50. G. W. Lynch, P.W. Selleck, and A.-M. Axell, “Cross-reactive anti-avian H5N1 influenza neutralizing antibodies in a normal “exposure-naïve” Australian blood donor population,” The Open Immunology Journal, vol. 1, pp. 13–19, 2008. View at Google Scholar
  51. A. Yamashita, N. Kawashita, R. Kubota-Koketsu et al., “Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: implication for human monoclonal antibody recognition,” Biochemical and Biophysical Research Communications, vol. 393, no. 4, pp. 614–618, 2010. View at Publisher · View at Google Scholar · View at Scopus